FDA Inspection 1199001 — Octapharma Plasma Inc
The FDA completed an inspection of Octapharma Plasma Inc on February 15, 2023 in Florence, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 15, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Florence, SC (United States)